Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres








Gamme d'année
1.
Iranian Journal of Public Health. 2012; 41 (5): 105-109
de Anglais | IMEMR | ID: emr-161735

RÉSUMÉ

Pemphigus vulgaris is a life threatening, blistering skin disease. It is an autoimmune abnormality. Due to involvement of oral cavity and pharynx, patients are at risk of nutrients deficiency. The aim of this study was to evaluate the status of selenium, copper, and zinc in these patients. In a case-control study, 43 newly diagnosed pemphigus vulgaris patients were compared with 58 healthy people from 2009 to 2010. The severity of the disease was estimated according to Harman's scores. Serum selenium was measured with atomic absorption but serum zinc and copper concentrations were determined spectrophotometrically. Data were compared with independent t test. Correlations were evaluated by Pearson correlation test. Both groups were the same based on sex, age, and weight and body mass index. The mean duration of disease was 5.6 month. The oral and skin severities were 1.79 and 2.3 respectively, based on Harman's scores. Serum selenium of pemphigus patients was significantly less than that of healthy people [P<0.001]. Serum copper was negatively correlated with duration of disease in males [P=0.02, r=-0.5]. Pemphigus vulgaris negatively affects on serum selenium, copper and zinc. It seems that serum selenium, copper and zinc decrease as the disease lasts longer

2.
Iranian Journal of Public Health. 2010; 39 (1): 57-63
de Anglais | IMEMR | ID: emr-93128

RÉSUMÉ

Atopic dermatitis is a public health problem worldwide. Increment of reactive oxygen species [ROS] production may be one of the contributing factors of tissue damage in atopic dermatitis. The present study was designed to determine the effect of vitamins E and/or D on erythrocyte superoxide dismutase and catalase activities in patients with atopic dermatitis. In a randomized, double blind, placebo controlled clinical trial 45 atopic dermatitis patients were divided into four groups. Each group received one of the following supplements for 60 days: group A [n = 11] vitamins E and D placebos; group B [n= 12] 1600 international unit [IU] vitamin D3 plus vitamin E placebo; group C [n=11] 600 IU synthetic all -rac-a tocopherol plus vitamin D placebo; group D [nM] 1600 IU vitamin D3 plus 600 IU synthetic all -rac-a tocopherol. Erythrocyte superoxide dismutase [SOD] and catalase activities, serum 25 [OH] D, plasma a-tocopherol were determined. The data were analyzed by analysis of variance [ANOVA] and paired /test. After 60 days vitamin D and E supplementation, erythrocyte SOD activities increased in groups B, C and D [P= 0.002, P= 0.016 and P= 0.015, respectively]. Erythrocyte catalase activities increased in groups B and D [P= 0.026 and.P= 0.004, respectively]. The increment of erythrocyte catalase activity was not significant in group C. There was a positive significant correlation between SOD activity and serum 25 [OH] D [r= 0.378, P= 0.01]. It is concluded that vitamin D is as potent as vitamin E in increasing the activities of erythrocyte SOD and catalase in atopic dermatitis patients


Sujet(s)
Humains , Adolescent , Adulte , Mâle , Femelle , Tocophérols , Calcifédiol , Superoxide dismutase , Catalase , Compléments alimentaires , Méthode en double aveugle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE